JPS5381611A - Hepatic medicine - Google Patents
Hepatic medicineInfo
- Publication number
- JPS5381611A JPS5381611A JP16000176A JP16000176A JPS5381611A JP S5381611 A JPS5381611 A JP S5381611A JP 16000176 A JP16000176 A JP 16000176A JP 16000176 A JP16000176 A JP 16000176A JP S5381611 A JPS5381611 A JP S5381611A
- Authority
- JP
- Japan
- Prior art keywords
- hepatic
- medicine
- hepatic medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002440 hepatic effect Effects 0.000 title 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16000176A JPS5381611A (en) | 1976-12-28 | 1976-12-28 | Hepatic medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16000176A JPS5381611A (en) | 1976-12-28 | 1976-12-28 | Hepatic medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5381611A true JPS5381611A (en) | 1978-07-19 |
Family
ID=15705821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16000176A Pending JPS5381611A (en) | 1976-12-28 | 1976-12-28 | Hepatic medicine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5381611A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002055075A3 (en) * | 2000-11-10 | 2003-12-31 | The President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
| EP1499186A4 (en) * | 2002-04-15 | 2009-10-28 | Beth Israel Hospital | USE OF HEM-OXYGENASE-1 AND HEM-DEGRADABLE PRODUCTS |
-
1976
- 1976-12-28 JP JP16000176A patent/JPS5381611A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002055075A3 (en) * | 2000-11-10 | 2003-12-31 | The President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
| EP1499186A4 (en) * | 2002-04-15 | 2009-10-28 | Beth Israel Hospital | USE OF HEM-OXYGENASE-1 AND HEM-DEGRADABLE PRODUCTS |
| US8097585B2 (en) | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5379020A (en) | Isosorbido containing medicine | |
| JPS52143218A (en) | Pharmaceutical composition | |
| JPS5348392A (en) | Syringe | |
| JPS5376171A (en) | Capsule | |
| JPS52113976A (en) | Pharmaceutical composition | |
| JPS5362838A (en) | Pharmaceutical composition | |
| JPS5372814A (en) | Pharmaceutical composition | |
| JPS5296717A (en) | Medicine addition system | |
| JPS5384700A (en) | Display | |
| JPS5326181A (en) | Gammaaradiation counter | |
| JPS5367397A (en) | Display | |
| AU3152677A (en) | Pharmaceutical composition | |
| JPS532394A (en) | Thermooluminescent substances | |
| JPS5369822A (en) | Pharmaceutical agent | |
| JPS52128357A (en) | Antiitumor drug | |
| JPS5356634A (en) | Pharmaceutical composition | |
| AU2649977A (en) | Pharmaceutical composition | |
| JPS5325579A (en) | Pharmaceutical compound | |
| JPS52113954A (en) | Local pharmaceutical agent containing clindamycine | |
| JPS52114010A (en) | Medicine for nicotinism | |
| JPS52114014A (en) | Llmenthol containing medicine | |
| JPS5283918A (en) | Pharmaceutical composition | |
| JPS5338620A (en) | Isomalin antiimold drug | |
| ZA777335B (en) | Pharmaceutical compounds | |
| JPS535681A (en) | Counter |